Who has invested in Cimeio Therapeutics?

Versant Ventures are named among the investors backing Cimeio Therapeutics.

Cimeio Therapeutics Funding: $50M Raised, Series A (2022)

Cimeio Therapeutics funding overview

Cimeio Therapeutics is based in Basel, Switzerland. Cimeio Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2022. The round record for Cimeio Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Versant Ventures.

Cimeio Therapeutics at a glance

Total raised: $50M
Latest round: Series A
Latest round date: April 2022
Headquarters: Basel, Switzerland
Notable investors: Versant Ventures

Frequently asked about Cimeio Therapeutics funding

How much has Cimeio Therapeutics raised?: Cimeio Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Cimeio Therapeutics?: Versant Ventures are named among the investors backing Cimeio Therapeutics.
What was the latest Cimeio Therapeutics funding round?: The most recent disclosed round is a Series A, announced in April 2022.
Where is Cimeio Therapeutics based?: Cimeio Therapeutics is based in Basel, Switzerland.
When did Cimeio Therapeutics last raise?: The last disclosed Cimeio Therapeutics round closed in April 2022 at Series A.

Round data for Cimeio Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Basel and backer lists below.

Cimeio Therapeutics Funding: $50M Raised, Series A (2022)

Cimeio Therapeutics funding overview

Cimeio Therapeutics at a glance

Frequently asked about Cimeio Therapeutics funding

Companies related to Cimeio Therapeutics (34)

Browse related funding lists (4)